Meifeng Chen

Key Laboratory Of Early Prevention And Treatment For Regional High Frequency Tumor
Nanning, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

A Noninvasive Predictive Model of Portal Hypertension in Patients with HCC Based on Clinical Features and Intra- and Peritumoral Pre-Fusion Radiomic Features.

A Noninvasive Predictive Model of Portal Hypertension in Patients with HCC Based on Clinical Features and Intra- and Peritumoral Pre-Fusion Radiomic Features.

Journal: Journal of hepatocellular carcinoma

Published: January 15, 2026

Neoadjuvant or conversion therapy nullifies the prognostic impact of surgical margin width in hepatocellular carcinoma: a single-center retrospective study.

Neoadjuvant or conversion therapy nullifies the prognostic impact of surgical margin width in hepatocellular carcinoma: a single-center retrospective study.

Journal: BMC surgery

Published: January 01, 2026

Neoadjuvant or conversion therapy nullifies the prognostic impact of surgical margin width in hepatocellular carcinoma: a single-center retrospective study.

Neoadjuvant or conversion therapy nullifies the prognostic impact of surgical margin width in hepatocellular carcinoma: a single-center retrospective study.

Journal: BMC surgery

Published: January 01, 2026

10-Hydroxy-2-decenoic Acid, a Bioactive Component of Royal Jelly, Induces p53-Mediated Apoptosis in Cholangiocarcinoma In Vitro and In Vivo.

10-Hydroxy-2-decenoic Acid, a Bioactive Component of Royal Jelly, Induces p53-Mediated Apoptosis in Cholangiocarcinoma In Vitro and In Vivo.

Journal: European journal of pharmacology

Published: December 20, 2025

RRx-001 inhibits G6PD to deplete NADPH and trigger disulfidptosis coupled with DAMP-mediated immunogenic cell death in hepatocellular carcinoma.

RRx-001 inhibits G6PD to deplete NADPH and trigger disulfidptosis coupled with DAMP-mediated immunogenic cell death in hepatocellular carcinoma.

Journal: Cell death discovery

Published: September 23, 2025

Pan-cancer analysis of HOMER1 in hepatocellular carcinoma revealing diagnostic potential and immune landscape with experimental validation.

Pan-cancer analysis of HOMER1 in hepatocellular carcinoma revealing diagnostic potential and immune landscape with experimental validation.

Journal: Discover oncology

Published: July 11, 2025

Application of propensity score matching in prognostic analysis of portal hypertension in hepatocellular carcinoma patients.

Application of propensity score matching in prognostic analysis of portal hypertension in hepatocellular carcinoma patients.

Journal: Frontiers in oncology

Published: June 10, 2025

Structural characterization and functional role of SLC7A6 in GSSG transport and Ferroptosis regulation.

Structural characterization and functional role of SLC7A6 in GSSG transport and Ferroptosis regulation.

Journal: International journal of biological macromolecules

Published: June 06, 2025

2-Dodecyl-6-Methoxycyclohexa-2,5-Diene-1,4-Dione from Averrhoa carambola L. roots: Suppressing hepatocellular carcinoma progression through ROS accumulation and p53 pathway-mediated apoptosis.

2-Dodecyl-6-Methoxycyclohexa-2,5-Diene-1,4-Dione from Averrhoa carambola L. roots: Suppressing hepatocellular carcinoma progression through ROS accumulation and p53 pathway-mediated apoptosis.

Journal: Toxicology and applied pharmacology

Published: December 10, 2024

Artificial intelligence algorithm was used to establish and verify the prediction model of portal hypertension in hepatocellular carcinoma based on clinical parameters and imaging features.

Artificial intelligence algorithm was used to establish and verify the prediction model of portal hypertension in hepatocellular carcinoma based on clinical parameters and imaging features.

Journal: Journal of gastrointestinal oncology

Published: November 29, 2024

Ansofaxine Hydrochloride inhibits hepatocellular carcinoma growth and enhances targeted therapy through the EGFR/MAPK pathway.

Ansofaxine Hydrochloride inhibits hepatocellular carcinoma growth and enhances targeted therapy through the EGFR/MAPK pathway.

Journal: Frontiers in oncology

Published: November 06, 2024

Donafenib activates the p53 signaling pathway in hepatocellular carcinoma, induces ferroptosis, and enhances cell apoptosis.

Donafenib activates the p53 signaling pathway in hepatocellular carcinoma, induces ferroptosis, and enhances cell apoptosis.

Journal: Clinical and experimental medicine

Published: October 25, 2024

Showing 1-12 of 17

Last Updated: 09/26/2026